Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia

The Journal of Clinical Endocrinology and Metabolism
Cecilia FollinEva Marie Erfurth

Abstract

Survivors of childhood-onset (CO) acute lymphoblastic leukemia (ALL) treated with prophylactic cranial radiotherapy often exhibit GH deficiency (GHD), which is associated with increased prevalence of cardiovascular risk factors and cardiac dysfunction. The objective of the study was to evaluate the effect of GH replacement on cardiovascular risk factors and cardiac function in former CO ALL patients. Eighteen former CO ALL patients (aged 19-32 yr) treated with cranial radiotherapy (18-24 Gy) and chemotherapy and with confirmed GHD were studied at baseline and after 12 (n = 18) and 24 months (n = 13) of GH treatment (median 0.5 mg/d). A group of 18 age- and sex-matched subjects served as controls. After 12 months of GH treatment, a significant decrease in serum leptin (P = 0.002), leptin per kilogram fat mass (FM) (P = 0.01), plasma glucose (P = 0.004), FM (P = 0.002), and hip (P = 0.04) and waist (P = 0.02) circumference and increased muscle mass (P = 0.004) were recorded in the patients. Before GH treatment six patients had a metabolic syndrome, but after 12 months only one had it and after 24 months none. After 24 months of GH treatment, an increase in left ventricular mass index (P = 0.06) and significant improvements in car...Continue Reading

Citations

Mar 26, 2008·Current Treatment Options in Oncology·Daniel A MulrooneyMelissa M Hudson
Jul 17, 2007·Current Opinion in Pediatrics·Meilan M Rutter, Susan R Rose
Jan 9, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Lillian R MeachamAnn C Mertens
Nov 15, 2011·Diabetes Research and Clinical Practice·Hyun-Suk JungHong Gwan Seo
Mar 10, 2016·Current Treatment Options in Oncology·Todd M GibsonKirsten K Ness
Mar 9, 2007·Critical Reviews in Oncology/hematology·C A J BrouwerA Postma
Mar 6, 2007·Endocrinology and Metabolism Clinics of North America·Indraneel Banerjee, Peter E Clayton
Apr 2, 2016·Nature Reviews. Endocrinology·Susan R RoseSarah D Corathers
Mar 17, 2015·Clínica e investigación en arteriosclerosis : publicación oficial de la Sociedad Española de Arteriosclerosis·Carlos LahozJosé M Mostaza
Aug 27, 2014·Endocrine·Maria Felicia FaienzaAnnamaria Ventura
Oct 9, 2014·Frontiers in Pediatrics·Nicole Barnes, Wassim Chemaitilly
May 18, 2016·Current Treatment Options in Cardiovascular Medicine·Syed S Mahmood, Anju Nohria
Nov 27, 2018·Endocrine Reviews·Judith GebauerGeorg Brabant
Sep 1, 2008·Expert Review of Endocrinology & Metabolism·Fausto BogazziEnio Martino
Nov 10, 2011·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Heidi Chamberlain Shea, Richard A Levy
May 18, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Jung-Yun LeeKyung-Hyun Choi
May 31, 2017·Metabolic Syndrome and Related Disorders·Paul SaultierGérard Michel
Jul 12, 2017·Annals of Pediatric Endocrinology & Metabolism·Hee Won Chueh, Jae Ho Yoo
Feb 16, 2010·The Lancet Oncology·Esther C de HaasJourik A Gietema
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.